Fedha

Hisa unazofuatilia
BMYB34:BVMF
Bristol-Myers Squibb Company BDR
R$ 331.90
+0.65%
(+2.15) Siku 1
30 Sep, 11:31:25 GMT -3  ·   BRL
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BMYB34...
Mtaji wa soko
121.52B
Wastani wa kiasi cha mauzo
3.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 347.15
Chini kwa wiki 52
R$ 221.72
Hisa za wawekezaji
2.04B
Idadi ya wafanyakazi
elfu 32
Mtaji wa soko
121.52B
Wastani wa kiasi cha mauzo
3.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 347.15
Chini kwa wiki 52
R$ 221.72
Hisa za wawekezaji
2.04B
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Kuhusu Bristol-Myers Squibb Company BDR
Afisa Mkuu Mtendaji (CEO)Chris Boerner
Wafanyakazielfu 32.5
Lilianzishwa1887
Makao makuuNew York, New York, Marekani
Sekta-
Tovutibms.com
Ripoti ya mwisho
30 Jul 2026
Kipindi cha Kifedha
Robo2 2026
Mapato kwa kila hisa dhidi ya makadirio (USD)
US$ 2.04 / US$ 1.60
+27.74%umepitiliza
Mapato dhidi ya makadirio (USD)
12.97B / 11.74B
+10.53%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
12.22B
12.50B
11.49B
12.97B
Gharama ya bidhaa zilizouzwa
3.31B
3.51B
3.41B
3.71B
Gharama ya mapato
3.31B
3.51B
3.41B
3.71B
Gharama za utafiti na maendeleo
2.43B
2.56B
2.24B
2.54B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.79B
2.09B
1.61B
1.82B
Gharama ya uendeshaji
5.05B
5.47B
4.28B
4.80B
Jumla ya gharama za uendeshaji
8.36B
8.98B
7.69B
8.51B
Mapato ya uendeshaji
3.86B
3.52B
3.80B
4.46B
Mapato mengine yasiyo ya uendeshaji
529.00M
544.00M
125.00M
106.00M
EBT ikijumuisha vipengee visivyo vya kawaida
3.11B
1.47B
3.24B
4.09B
EBT bila kujumuisha vipengee visivyo vya kawaida
4.07B
3.86B
3.65B
4.35B
Gharama ya kodi ya mapato
919.00M
384.00M
561.00M
770.00M
Kiwango cha kodi kinachotumika
29.51%
26.12%
17.32%
18.84%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
2.20B
1.09B
2.68B
3.32B
Kiwango cha faida halisi
18.01%
8.69%
23.30%
25.57%
Mapato kwa kila hisa
1.63
1.26
1.58
2.04
Mapato ya riba na uwekezaji
161.00M
148.00M
104.00M
101.00M
Gharama ya riba
-482.00M
-432.00M
-406.00M
-403.00M
Jumla ya gharama halisi za riba
-321.00M
-284.00M
-302.00M
-302.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
4.91B
4.54B
4.41B
5.08B
Faida au hasara kutokana na uuzaji wa vipengee
-9.00M
-
-34.00M
-142.00M
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google